Global Nasogastric Tube Market Analysis & Trends - Industry Forecast to 2030
Nasogastric Tube: Market Size
From $510.3 million in 2024, the global Nasogastric Tube market is projected to reach $855.9 million by 2030. Based on our analysis the market is expected to grow at a CAGR of 9.0% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing include rise in prevalence of chronic diseases, increase in the number of preterm births, and surge in geriatric population base.
Global Nasogastric Tube Market: Market Dynamics
Major factors driving the usage of nasogastric tubes include the administration of medication and nutrients, addition of contrast to the stomach for X-rays, protection of the bowel post-surgery or during bowel rest, and removal of air or liquids from the stomach. Rising prevalence of chronic ailments including diabetes, cancer, cardiovascular diseases, respiratory and gastrointestinal diseases resulting into increase of patient pools are the key factors driving the growth of nasogastric tubes market. The rising incidences of hospitalization among both pediatric and elderly populace will offer lucrative avenues for the business growth as nasogastric tubes are increasingly required in hospitals for facilitating enteral feeding, providing medicinal support and gastric decompression. Additionally, changing trends pertaining shift to enteral from parenteral feeding and rising consciousness among populace regarding enteral feeding will foster the industry growth in the near future.
On the other hand, the developmental delays and side effects such as retching, tube dislocation, tube perforation, gagging, and skin irritation are likely to obstruct the profit boundaries. In addition, rising demand for enteral nutrition, advancements in the medical field, and reduction in the cost of treatments along with use of various multi-faceted therapies against number of chronic diseases will further boost for the nasogastric tube market.
Impact of COVID-19 on Nasogastric Tube
The COVID-19 pandemic has led to an increase in studies for enhancing the efficiency of enteral feeding for ICU (Intensive Care Units) patients. This is because the SARS-CoV-2 population might be at a greater risk due to the requirement for emergence delirium, long duration of invasive ventilation, and the need for proning. Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to enteral nutrition has been reduced and this segment have to face negligence subsequently causing negative impact on nasogastric tubes market. On the other hand, according to one such study, the usage of nasogastric tube bridle kits decreases the count of NGT insertions that are required by patients and also lowers the number of chest radiographs required by them. Such findings are predicted to the development of efficient nasogastric tube feeding equipment through the pandemic period.
By End User
Hospitals Segment Dominate the Market in 2024
The hospitals segment made huge revenue in 2024 and growing its prominence during the forecast period. The growing occurrence of ingestion and gastrointestinal problems among the aging population is the major factor propelling the hospital segment. When such cases occur, essential nutrients are supplemented via the enteral route, which positively influences the demand for nasogastric tube feeding. The segmental expansion is further being driven by the expanding geriatric pool and the escalating incidence of chronic diseases across various regions.
By Geography
North America Region is Leading in the Global Market Place
North America region is likely to have a huge demand in the forecast period owing to the formulation of various regulatory guidelines in the region. For example, in June 2021, the U.S. FDA issued recommendations for testing the suitability of oral drug products for enteral feeding tube administration. These developments drive the need for efficient nasogastric tubes given that these could be required for the maintenance of adequate nutrition for various reasons such as cancer, swallowing difficulty, severe genetic or acquired neurological impairment, and other diseases.
List of the Key Players Profiled in the Market Include: • Andersen Products
• Bard Medical
• Becton, Dickinson and Company
• Bicakcilar AS
• Cardinal Health
• Degania Medical
• Guangdong Baihe Medical Technology Co., Ltd.
• Hangzhou Formed Medical Devices Co., Ltd.
• Pacific Hospital Supply Co., Ltd.
• Poly Medicure Limited
• Q Holding Company
• Rontis Medical
• SecurMed
• Vygon SA
• Well Lead Medical Co., Ltd.
List of the Regions/Countries Profiled in the Market Include: North America
• US
• Canada
• Mexico
Europe
• Germany
• U.K
• Italy
• France
• Spain
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• New Zealand
• Rest of Asia Pacific
Middle East
• Saudi Arabia
• UAE
• Rest of Middle East
Latin America
• Argentina
• Brazil
• Rest of Latin America
Rest of the World (RoW)
• South Africa
• Others